All
Patients With Cancer Strongly Encouraged to Get COVID-19 Boosters to Protect Against Omicron Variant
January 18th 2022A booster dose of the COVID-19 mRNA vaccine may provide patients with cancer with a broader and stronger protection against COVID-19 variants like omicron, according to a cancer researcher at The Ohio State University Comprehensive Cancer Center.
Trial to Assess Dose Escalation of Experimental Drug Plus Immunotherapy in Solid Tumors Begins
January 18th 2022The STELLAR-002 trial is currently underway to examine the combination of XL092, an experimental tyrosine kinase inhibitor, in combination with immuno-oncology therapies for patients with advanced solid tumors.
Partner-Inclusive Interventions May Help Recover Sexual Intimacy After Prostate Cancer
January 17th 2022Prostate cancer survivors are encouraged to include their partners in interventions to improve sexual function after treatment — and, as study results show, it is better to have these conversations with providers sooner rather than later.
FDA Speeds Up Review of Enhertu for Previously Treated Unresectable/Metastatic HER2-Breast Cancer
January 17th 2022After the drug showed promising results in the DESTINY-Breast03 trial, the FDA granted Enhertu a priority review, meaning that it plans to make its approval decision on it by the end of the second quarter of 2022.
Higher BMI in Adulthood May Limit the Immune System’s Ability to Fight Breast Cancer
January 14th 2022New findings demonstrated that adult patients with breast cancer and increased BMI had an association with different types of immune cells around their tumors that may affect how their body attacks the cancer cells.